NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Patients with vertebral fractures, particularly severe fractures, may face greater risks for worsening spinal degeneration.

Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

He's the latest addition to OKC's lengthy list of injuries, which also includes Chet Holmgren (right iliac wing fracture) and Jaylin Williams (right hamstring). Flagler is a second-year guard out ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and ...

He averaged 3.5 points and 2.6 rebounds in 16 games. This injury is brutal for Dieng, who hoped to establish himself as a rotation player. The 21-year-old's third season will likely decide his ...

A Phase I clinical trial has demonstrated the long-term safety of neural stem cell transplantation for chronic spinal cord ...

Pedestrian accidents are unfortunately common in Denver, given the city’s busy streets and heavy traffic. Whether you’ve been hit by a car while crossing the street, walking along a sidewalk, or ...